Alzheimer's research pivots to tau, blood-brain barrier

At the Alzheimer’s Association International Conference (AAIC), researchers highlighted new strategies targeting tau proteins and improving drug delivery across the blood-brain barrier. The focus moves beyond solely amyloid plaques, hinting at more effective interventions for cognitive decline.